AR085801A1 - Uso de una composicion pulverizable que contiene ambroxol, metodo - Google Patents
Uso de una composicion pulverizable que contiene ambroxol, metodoInfo
- Publication number
- AR085801A1 AR085801A1 ARP120100824A ARP120100824A AR085801A1 AR 085801 A1 AR085801 A1 AR 085801A1 AR P120100824 A ARP120100824 A AR P120100824A AR P120100824 A ARP120100824 A AR P120100824A AR 085801 A1 AR085801 A1 AR 085801A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition containing
- spray composition
- ambroxol hydrochloride
- containing ambroxol
- ambroxol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Clorhidrato de ambroxol para el tratamiento de faringitis aguda, en el que el clorhidrato de ambroxol se aplica localmente y en forma de una composición pulverizable que contiene de 1 a 30 mg/ml de clorhidrato de ambroxol, en una dosis de 1 a 20 mg.Reivindicación 10: Composición acuosa pulverizable para el tratamiento de faringitis aguda, caracterizada porque contiene de 1 a 30 mg/ml de clorhidrato de ambroxol, de 50 a 200 mg/ml de etanol, de 0,5 a 2 mg/ml de un tensioactivo, así como otros aditivos seleccionados de entre sustancias reguladoras del pH, edulcorantes, aromatizantes y/o conservantes.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11158043 | 2011-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR085801A1 true AR085801A1 (es) | 2013-10-30 |
Family
ID=44501830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP120100824A AR085801A1 (es) | 2011-03-14 | 2012-03-13 | Uso de una composicion pulverizable que contiene ambroxol, metodo |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10959964B2 (es) |
| EP (1) | EP2685960B1 (es) |
| JP (1) | JP5930332B2 (es) |
| AR (1) | AR085801A1 (es) |
| BR (1) | BR112013023337A2 (es) |
| CA (1) | CA2829832C (es) |
| EA (1) | EA027291B1 (es) |
| ES (1) | ES2715614T3 (es) |
| MX (1) | MX2013010456A (es) |
| UA (1) | UA112541C2 (es) |
| WO (1) | WO2012123466A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112168782A (zh) * | 2020-10-26 | 2021-01-05 | 山东裕欣药业有限公司 | 一种呼吸系统药物口服喷雾剂的制备方法 |
| CN112168783A (zh) * | 2020-10-26 | 2021-01-05 | 山东裕欣药业有限公司 | 一种呼吸系统药物口服喷雾剂及制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6159459A (en) * | 1995-05-01 | 2000-12-12 | Colgate Palmolive Company | Oral lubricating composition |
| JPH10259124A (ja) * | 1997-03-19 | 1998-09-29 | Taisho Pharmaceut Co Ltd | 咽頭疾患用組成物 |
| US20050075403A1 (en) * | 2003-10-02 | 2005-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol for the treatment of inflammation in the pharynx |
| ITMI20032463A1 (it) | 2003-12-16 | 2005-06-17 | Advance Holdings Ltd | Soluzione acquosa concentrata a base di ambroxolo |
| DE102004021992A1 (de) * | 2004-05-03 | 2005-11-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Topische Zubereitung enthaltend Ambroxol |
| CN1695601A (zh) * | 2005-05-18 | 2005-11-16 | 湖北南洋药业有限公司 | 盐酸氨溴索气雾剂及其制备方法 |
| US20080319087A1 (en) | 2005-08-25 | 2008-12-25 | Anke Esperester | Use of Ambroxol for the Treatment of Rhinovirus Infections |
| EP1820493A3 (en) | 2006-02-10 | 2008-05-07 | PARI Pharma GmbH | Aerosols for sinunasal drug delivery |
| CN101606903A (zh) * | 2008-06-19 | 2009-12-23 | 北京韩美药品有限公司 | 一种氨溴索的雾化吸入用溶液剂及其制备方法 |
| CN101810604A (zh) * | 2009-02-25 | 2010-08-25 | 北京利乐生制药科技有限公司 | 一种以沙丁胺醇与氨溴索为活性成分的喷雾剂 |
-
2012
- 2012-03-13 EP EP12709083.5A patent/EP2685960B1/de active Active
- 2012-03-13 BR BR112013023337A patent/BR112013023337A2/pt not_active Application Discontinuation
- 2012-03-13 US US14/003,375 patent/US10959964B2/en active Active
- 2012-03-13 AR ARP120100824A patent/AR085801A1/es unknown
- 2012-03-13 CA CA2829832A patent/CA2829832C/en not_active Expired - Fee Related
- 2012-03-13 MX MX2013010456A patent/MX2013010456A/es not_active Application Discontinuation
- 2012-03-13 WO PCT/EP2012/054406 patent/WO2012123466A1/de active Application Filing
- 2012-03-13 JP JP2013558411A patent/JP5930332B2/ja active Active
- 2012-03-13 EA EA201301021A patent/EA027291B1/ru not_active IP Right Cessation
- 2012-03-13 ES ES12709083T patent/ES2715614T3/es active Active
- 2012-03-13 UA UAA201311931A patent/UA112541C2/uk unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2829832C (en) | 2019-07-30 |
| EP2685960A1 (de) | 2014-01-22 |
| WO2012123466A1 (de) | 2012-09-20 |
| US10959964B2 (en) | 2021-03-30 |
| BR112013023337A2 (pt) | 2016-12-13 |
| UA112541C2 (uk) | 2016-09-26 |
| JP5930332B2 (ja) | 2016-06-08 |
| EA201301021A1 (ru) | 2014-03-31 |
| ES2715614T3 (es) | 2019-06-05 |
| MX2013010456A (es) | 2013-10-28 |
| EP2685960B1 (de) | 2018-12-19 |
| US20140066518A1 (en) | 2014-03-06 |
| JP2014511828A (ja) | 2014-05-19 |
| CA2829832A1 (en) | 2012-09-20 |
| EA027291B1 (ru) | 2017-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017001493A2 (es) | Kits que comprenden inhibidores tigit y agentes anticáncer | |
| CL2012001659A1 (es) | Composición acuosa antitranspirante/desodorante que comprende a) un activo antitranspirante b) mezcla que comprende al menos una amida básica y/o una amina básica y un material de contraparte para dicha amida y/o amina y c) al menos el 10% en agua; método para producirla; y método para aplicarla. | |
| AR082381A1 (es) | Composicion acuosa que contiene bromhexina | |
| NZ712270A (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| CO6280584A2 (es) | Derivados heterociclicos fungicidas de (tetrazolil-benzilideneamido)-oximetil | |
| BR112015020466A8 (pt) | inibidores de cdc7, seus usos, e composição farmacêutica | |
| MX2015016421A (es) | Derivados de pirazolo-pirrolidin-4-ona como inhibidores de bet y su uso en el tratamiento de enfermedades. | |
| BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
| MX2016003823A (es) | Inhibidor selectivo de fosfatidil-inositol 3-cinasa-gamma. | |
| AR081520A1 (es) | Composicion farmaceutica que comprende una dispersion solida de tacrolimus en un vehiculo | |
| GT201500035A (es) | Composición farmacéutica oral en forma de microesferas y proceso de elaboración | |
| DOP2009000207A (es) | Nueva forma de dosificación | |
| CR20140053A (es) | Formulaciones de ácido desoxicólico y sales del mismo | |
| AR096705A1 (es) | Composición que comprende ácido glutámico-n,n-diacetato (glda), agua y enzima | |
| AR100365A1 (es) | Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla | |
| CR20110022A (es) | Nuevas posibilidades de lucha contra la giardiasis | |
| UY34647A (es) | Composiciones farmacéuticas | |
| AR085801A1 (es) | Uso de una composicion pulverizable que contiene ambroxol, metodo | |
| CO2018001831A2 (es) | Composición de absorción percutánea en forma de parche | |
| AR083658A1 (es) | Composicion nasal de metilcobalamina y el proceso para preparar la misma | |
| CL2015001940A1 (es) | Formulación que comprende un compuesto de benzotiazolona. | |
| CO2019008657A2 (es) | Composición intranasal que comprende betahistina | |
| AR103381A1 (es) | Composición farmacéutica para el tratamiento de micosis | |
| ECSP18094376A (es) | Uso de 9-tricoseno para controlar la drosophila suzukii | |
| ES2475942B1 (es) | Composición farmacéutica de citrato de sildenafilo en forma de solución acuosa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |